Amy Goundry Takes on The Role of Managing Editor for Therapeutic Advances in Cardiovascular Disease
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”I’ve recently taken on the role of Managing Editor for Therapeutic Advances in Cardiovascular Disease, a gold open access journal dedicated to advancing clinical care across the full spectrum of cardiac and circulatory conditions.
The journal is shaped by a global community of researchers and clinicians who care about evidence that informs real treatment decisions — from pharmacological innovations to interventional strategies and other therapeutic approaches that move us closer to precision cardiovascular care.
Always glad to connect with researchers and clinicians helping to shape the conversation in cardiovascular care — whether by sharing their research or contributing to the journal’s editorial community!”
Find the Journal here.
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis